The BalancedInvestor Club

SPRC Market Analysis

Overview

Fundamentals

P/E ratio0.00
EPS (TTM)$3,156.520.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$4.5MMicro cap

Valuation

Forward P/E
—
PEG ratio
—
P/B
0.49
P/S (TTM)
3.42
EV/EBITDA
1.21

Profitability & growth

ROE (TTM)
-1281.0%
Operating margin
-570.0%
Revenue growth YoY
-45.1%
Dividend yield
—
Beta
1.33
Last earnings
Apr 24, 2025 · Estimate $0.00 · Reported $-6.20
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Scisparc Ltd

SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.

Classification

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
TOWER A, TEL AVIV-YAFO, ISRAEL
Fiscal year end
December
Latest quarter
Sep 30, 2025
Market cap$4.5M
Shares outstanding$565500
52W high$80.10
52W low$2.98

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer